Vilanterol

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 410 publications

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Assessing the Equitable Use of Formulary Drug Tier Systems: Consequences for Geriatric Patient Population Access and Accessible Medication.

Journal: Innovations in pharmacy

Published: June 08, 2026

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

Journal: JAMA network open

Published: March 09, 2026

Molecular docking approaches in mycetoma: Toward improved patient management.

Molecular docking approaches in mycetoma: Toward improved patient management.

Journal: PLoS neglected tropical diseases

Published: February 11, 2026

A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis.

A pragmatic, multicentre, placebo-controlled, 3-arm, double-blinded, randomised controlled trial, incorporating an internal pilot, to determine the role of bronchodilators in preventing exacerbations of bronchiectasis.

Journal: Health technology assessment (Winchester, England)

Published: February 09, 2026

Adverse event mining for Breztri and Trelegy Ellipta based on the three international pharmacovigilance databases.

Adverse event mining for Breztri and Trelegy Ellipta based on the three international pharmacovigilance databases.

Journal: Medicine

Published: January 26, 2026

Determination of Particle Size of Active Pharmaceutical Ingredients in Dry Powder Inhaler Formulations.

Determination of Particle Size of Active Pharmaceutical Ingredients in Dry Powder Inhaler Formulations.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 14, 2026

Optimizing COPD management in Latin America: a cost-effectiveness analysis of FF/UMEC/VI in Colombia.

Optimizing COPD management in Latin America: a cost-effectiveness analysis of FF/UMEC/VI in Colombia.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: December 11, 2025

Is Clinical Remission, an Ambitious Treatment Goal, Achievable in Patients with Moderate-to-Severe Asthma on Inhaled Therapies: How Ambitious Should We Be?

Is Clinical Remission, an Ambitious Treatment Goal, Achievable in Patients with Moderate-to-Severe Asthma on Inhaled Therapies: How Ambitious Should We Be?

Journal: Journal of clinical medicine

Published: December 10, 2025

Cardiovascular events in patients with COPD after long-acting bronchodilator initiation.

Cardiovascular events in patients with COPD after long-acting bronchodilator initiation.

Journal: ERJ open research

Published: November 28, 2025

Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidence.

Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidence.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 21, 2025

Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS.

Mining of Adverse Event Signals Associated with Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy: A Post-Marketing Analysis Based on FAERS.

Journal: Pharmacy (Basel, Switzerland)

Published: October 24, 2025

SERS fingerprinting of β2-agonists for anti-doping based on Au-COF substrate.

SERS fingerprinting of β2-agonists for anti-doping based on Au-COF substrate.

Journal: Analytica chimica acta

Published: October 09, 2025

Showing 1-12 of 410

Last Updated: 06/30/2026